Jifeng Li

机构：Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University, Shantou University, Second Affiliated Hospital of Guangzhou Medical University, Kanion Pharmaceutical (China), Beijing Institute of Neurosurgery, Second Affiliated Hospital of Shantou University Medical College, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Henan Provincial People's Hospital, Shantou Central Hospital, Xian Yang Central Hospital, The First People's Hospital of Zhaoqing, Guangzhou Medical University · ORCID：0000-0002-0418-6151

发表论文 130 篇 · 总被引 1636 次 · h-index 23

代表论文

• Polysaccharides from Chinese herbal medicine: a review on the hepatoprotective and molecular mechanism (2024 · Chinese Journal of Natural Medicines · 被引 39)
• Association of sdLDL-C With Incident Carotid Plaques With Stable and Vulnerable Morphology: A Prospective Cohort Study (2024 · Stroke · 被引 28)
• Serum proteome profiling reveals heparanase as a candidate biomarker for chronic thromboembolic pulmonary hypertension (2024 · iScience · 被引 25)
• Multi-kingdom gut microbiota dysbiosis is associated with the development of pulmonary arterial hypertension (2025 · EBioMedicine · 被引 13)
• Immune Markers and Inflammatory Cytokines in Granulomatous Lobular Mastitis: A Case-Control Study (2024 · Journal of Inflammation Research · 被引 12)
• China's coordinated tripartite medical reform: strategic balancing of interests among pharmaceuticals, healthcare, and health insurance (2025 · Frontiers in Public Health · 被引 10)